New surgical approach for rectal cancer in women aims to reduce bleeding

NCT ID NCT07189780

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This trial compares two surgical techniques for removing rectal cancer in women. The standard method cuts the peritoneum slightly above its lowest point, while the new method cuts exactly at the lowest point. Researchers believe the new technique may reduce blood loss and protect nearby structures. The study will enroll 200 women with mid-low rectal cancer who are scheduled for laparoscopic surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
surgical technique (precise peritoneal incision at the lowest point of the peritoneal reflection)
What this could lead to
If successful, this could establish a safer, more effective surgical approach for women with mid-low rectal cancer, reducing blood loss and improving recovery.
What could go wrong
This is an early-stage trial with only 200 participants, so results may not apply to all patients. The technique is a small change in procedure, so the benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MID-TO-LOW RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.